# Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation Study (REWRAPS)

> **NCT02024230** · PHASE4 · COMPLETED · sponsor: **Fujita Health University** · enrollment: 500 (actual)

## Conditions studied

- Coronary Artery Disease
- Atrial Fibrillation
- Stroke
- Fetal Blood Loss
- Major Bleeding
- All Cause Mortality

## Interventions

- **DRUG:** Rivaroxaban or Warfarin

## Key facts

- **NCT ID:** NCT02024230
- **Lead sponsor:** Fujita Health University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2018-12
- **Final completion:** 2022-12
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2023-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02024230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02024230, "Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation Study (REWRAPS)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02024230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*